These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2117390)

  • 1. Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: a case report.
    Tibaldi JM; Lorber DL; Nerenberg A
    Am J Obstet Gynecol; 1990 Aug; 163(2):509-10. PubMed ID: 2117390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoacidosis in pregnancy associated with the parenteral administration of terbutaline and betamethasone. A case report.
    Bernstein IM; Catalano PM
    J Reprod Med; 1990 Aug; 35(8):818-20. PubMed ID: 2120435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbutaline tocolysis and glucose intolerance.
    Regenstein AC; Belluomini J; Katz M
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):739-41. PubMed ID: 8469464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)?
    Bouhanick B; Biquard F; Hadjadj S; Roques MA
    Arch Intern Med; 2000 Jan; 160(2):242-3. PubMed ID: 10647766
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous insulin infusion in diabetic emergencies.
    Leslie RD; Mackay JD
    Br Med J; 1978 Nov; 2(6148):1343-4. PubMed ID: 102400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis.
    Smith CS; Woodland MB
    Am J Perinatol; 1993 Jul; 10(4):280-4. PubMed ID: 8397562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term subcutaneous terbutaline tocolysis: report of possible neonatal toxicity.
    Thorkelsson T; Loughead JL
    J Perinatol; 1991 Sep; 11(3):235-8. PubMed ID: 1919821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.
    MacRury SM; Small M; MacCuish AC
    Diabetes Res; 1987 Jul; 5(3):153-5. PubMed ID: 3117474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-sympathomimetic therapy of premature labor.
    Lorber D; Krim E
    Diabetes Care; 1996 Aug; 19(8):899. PubMed ID: 8842614
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial.
    Lewis R; Mercer BM; Salama M; Walsh MA; Sibai BM
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):834-7. PubMed ID: 8885731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic ketoacidosis in pregnancy resulting from insulin pump failure. A case report.
    Lindenbaum C; Menzin A; Ludmir J
    J Reprod Med; 1993 Apr; 38(4):306-8. PubMed ID: 8501740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked insulin resistance in pregnancy: a case report and literature review.
    Mancini JM; Issa N; Kosseifi SG; Peiris AN
    Tenn Med; 2006 Oct; 99(10):35-7. PubMed ID: 17375502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and insulin-dependent diabetes mellitus.
    Pedersen O; Beck-Nielsen H
    Diabetes Care; 1987; 10(4):516-23. PubMed ID: 3113899
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
    Razavi Z; Maher S; Fredmal J
    Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous infusion of terbutaline for suppression of preterm labor.
    Fischer JR; Kaatz BL
    Clin Pharm; 1991 Apr; 10(4):292-6. PubMed ID: 2032446
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients.
    Rosene KA; Featherstone HJ; Benedetti TJ
    Am J Obstet Gynecol; 1982 Jun; 143(4):405-7. PubMed ID: 7091205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
    Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
    Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ritodrine as a possibly provocative predictive test in gestational diabetes. A case report.
    Richards SR; Klingelberger CE
    J Reprod Med; 1987 Oct; 32(10):798-800. PubMed ID: 3119836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic acidosis in the 32nd week of pregnancy--uncontrolled diabetes in pregnancy, dehydration or sequela of tocolysis?].
    Gmehlin U; Stenz R; Stoz F
    Zentralbl Gynakol; 1994; 116(12):706-10. PubMed ID: 7846985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of intravenous nitroglycerin and subcutaneous terbutaline for external cephalic version under tocolysis.
    El-Sayed YY; Pullen K; Riley ET; Lyell D; Druzin ML; Cohen SE; Chitkara U
    Am J Obstet Gynecol; 2004 Dec; 191(6):2051-5. PubMed ID: 15592291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.